Search all trials

Find therapies in clinical trials near you – page 97

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Dry eye+1

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Ianalumab

Contact Research Centre

Acute myeloid leukaemia recurrent

Not recruiting

InvestigationalNo placebo

Study of Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ziftomenib

Contact Research Centre

Malignant melanoma stage III

Not recruiting

Registered drug

Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study of iberdomide alone or with drug combinations for patients with multiple myeloma: testing safety and effectiveness of different doses

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Thrombotic thrombocytopenic purpura

Not recruiting

Registered drugNo placebo

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Caplacizumab

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Alectinib

Contact Research Centre

Glycogen storage disease type II

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cipaglucosidase Alfa

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bendamustine

Contact Research Centre

Warm autoimmune haemolytic anaemia

Not recruiting

Registered drug

Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Danazol

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Find therapies in clinical trials near you – page 97

1 329 trials match your criteria

Dry eye+1

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Acute myeloid leukaemia recurrent

Study of Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Malignant melanoma stage III

Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

Plasma cell myeloma

Study of iberdomide alone or with drug combinations for patients with multiple myeloma: testing safety and effectiveness of different doses

HER2 positive breast cancer

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Non-small cell lung cancer

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Thrombotic thrombocytopenic purpura

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Neoplasm

Study on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors

Glycogen storage disease type II

Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease

Plasma cell myeloma

Study of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma

Warm autoimmune haemolytic anaemia

Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

Bladder cancer

Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.